–
Статьи в журналах
-
- 2021 MUSASHI-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-MUTATED non-small cell lung cancer (NSCLC)
- Makhov P., Bychkov I., Faezov B., Deneka A., Kudinov A., Nicolas E., Avril E., Kharin L.V., Topchu I., Fazliyeva R., Nikonova A.S., Serebriiskii I.G., Borghaei H., Golemis E.A., Boumber Y.*., Brebion R., Cai K.Q., Frantsiyants E., Karnaukhov N., Kit O.I., Voloshin M., Edelman M., Dulaimi E.
- в журнале ONCOGENESIS, том 10, № 3 DOI
-
- 2021 MUSASHI 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
- Topchu I., Mazitova A., Serebriiskii I., Boumber Y., Deneka A.*., Yugai V., Tikhomirova M., Abramova Z., Karnaukhov N., Voloshin M., Kit O., Frantsiyants E., Kharin L., Airapetova T., Ratner E., Sabirov A.
- в журнале Journal of thoracic disease, издательство Pioneer Bioscience Pub. Co. (Hong Kong, China), том 13, № 3, с. 1370-1379 DOI
-
- 2017 PROGNOSTIC SIGNIFICANCE OF LOCAL IMMUNITY FACTORS IN ESOPHAGEAL CANCER
- Kolesnikov E.N., Kit O.I., Zlatnik E.Y., Bazaev A.L., Maksimov A.Y., Novikova I.A., Selyutina O.N., Bondarenko E.S., Trifanov V.S., Kharin L.V., Gabrichidze P.N., Kozhushko M.A., Mezentsev S.S., Vladimirova L.Y.
- в журнале Annals of Oncology, издательство Oxford University Press (United Kingdom), том 28, с. 019